ACON Aclarion, Inc. Common Stock Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
18:09
Jan 10
Jan 10
ACON offering extends runway to 2027
The author argues Aclarion's $10.36 million offering strengthens the balance sheet, leaving $22-23 million in cash and extending the runway with no need for new offerings until 2027. Pricing the offering near market at $5.18 versus a $4.80 market price is claimed to minimize post-RDO price pressure and dilution. The author cites CEO Brent Ness on Nociscan adoption and forecasts shares reaching $25 in the near future. The main stated risk is that the share price could sit slightly below the offering price.
MED
About ACON Investor Commentary
Across the available history and selected sources, Buzzberg tracks ACON (Aclarion, Inc. Common Stock) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/LordWorl.